Rare diseases
Investigational molecules
Locations
Effect of zenagamtide on major adverse cardiovascular events in overweight or obese adults with established atherosclerotic cardiovascular disease
The NetherlandsStudy of vicadrostat and empagliflozin combination in patients with type 2 diabetes, high blood pressure and cardiovascular disease
The NetherlandsStudy on BI 690517 and Empagliflozin for Patients with Heart Failure and Preserved Ejection Fraction
The NetherlandsStudy on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History
The NetherlandsStudy on Clazakizumab for Heart Disease in Adults with End-Stage Kidney Disease on Dialysis
The NetherlandsRamantamig (JNJ-79635322) with drug combination versus standard therapy in newly diagnosed multiple myeloma patients not eligible for stem cell transplant
The NetherlandsStudy of pirtobrutinib plus epcoritamab in patients with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma
The NetherlandsRandomized Study of INCB161734 Plus Standard Chemotherapy Drug Combination in Untreated KRAS G12D Metastatic Pancreatic Ductal Adenocarcinoma Patients
The NetherlandsEvaluation of pembrolizumab and bevacizumab in patients with metastatic cervical cancer
The NetherlandsA study to evaluate the effectiveness of methotrexate in preventing the recurrence of dermatological vulvar intraepithelial neoplasia in women with lichen sclerosus.
The NetherlandsStudy of Zenagamtide (NNC0487-0111) versus placebo in patients with heart failure with preserved or mildly reduced ejection fraction and obesity
The NetherlandsStudy of pembrolizumab, capecitabine, or olaparib in patients with early-stage triple negative breast cancer and remaining disease after initial treatment
The NetherlandsTell us about your condition – we search every trial in Europe and connect you with the right site.
